ImmuneSensor Therapeutics
Dallas, US · Founded 2019
Biotech
Founders & leadership
QL
Qingsong LiExecutive Officer, Director
ZH
Zhi HongDirector
EW
Ernest WongExecutive Officer, Director
NZ
Ning ZhangDirector
Reported raises · per SEC filings
Form D private placements▶$10MraisedDec 2022 · 1 investors · BiotechnologyRule 506(b)
▶$10MraisedDec 2022 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Qingsong LiExecutive Officer, Director
- Zhi HongDirector
- Ernest WongExecutive Officer, Director
- Ning ZhangDirector
- Offering amount
- $20M
- Amount sold
- $10M
- First sale
- Nov 2022
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.